Uwe K Zettl

Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects

Isabelle Cournu-Rebeix, Frauke Zipp, Ulman Lindenberger, 2012, Journal of Medical Genetics.

Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome

Sara Llufriu, Xavier Montalban, Lluís Ramió-Torrentà, 2018, Brain : a journal of neurology.

Linguistic and psychometric validation of the MSSS-88 questionnaire for patients with multiple sclerosis and spasticity in Germany

Peter Flachenecker, U. Zettl, S. von Mackensen, 2014, Health and Quality of Life Outcomes.

Computational analysis of high-density peptide microarray data with application from systemic sclerosis to multiple sclerosis.

Hans-Jürgen Thiesen, Yixue Li, Peter Lorenz, 2012, Autoimmunity reviews.

Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation

Christian Gieger, Bernhard Hemmer, Mark Mühlau, 2016, Science Advances.

Long-term genome-wide blood RNA expression profiles yield novel molecular response candidates for IFN-beta-1b treatment in relapsing remitting MS.

Dirk Koczan, Michael Hecker, M. Hecker, 2010, Pharmacogenomics.

Multiple sclerosis therapy monitoring based on gene expression.

Steffen Möller, Dirk Koczan, Pablo Serrano-Fernández, 2006, Current pharmaceutical design.

Comparative genomics for the investigation of autoimmune diseases.

Steffen Möller, Pablo Serrano-Fernández, Robert Goertsches, 2006, Current pharmaceutical design.